Softbank China & India Holdings logo

Softbank China & India Holdings

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

Softbank China & India Holdings is a venture capital firm that invests in the internet, apps, media, entertainment, and other areas.

Investor Profile

Softbank China & India Holdings has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (33%)
  • Seed (33%)
  • Series B (33%)

Country Focus

  • China (67%)
  • United States (33%)

Industry Focus

  • Biopharma
  • Pharmaceutical
  • Biotechnology
  • Clinical Trials
  • Cloud Computing
  • Medical
  • Software
  • Cloud Management
  • Machine Learning
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Softbank China & India Holdings frequently co-invest with?

GL Ventures LLC
Asia, Beijing, China, Beijing
Co-Investments: 1
ZSVC
Asia, Beijing, China, Beijing
Co-Investments: 1
FanZhuo Capital
Asia, Beijing, China, Beijing Shi
Co-Investments: 1
Future Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Cowin Venture
Asia, Beijing, China, Beijing
Co-Investments: 1
Matrix Partners China
Asia, Beijing, China, Beijing
Co-Investments: 1
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
YF Capital
Asia, Shanghai, China, Jingan
Co-Investments: 1
Ivy Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Softbank China & India Holdings?

Corigine

Santa Clara, California, United States

Corigine delivers innovative solutions in connectivity, storage, and machine learning for cloud, automotive, and emerging applications.

Cloud ManagementMachine LearningSemiconductor
SeedMar 22, 2021
Amount Raised: $10,000,000
Taimei Technology

Jiaxing, Zhejiang, China

Taimei Technology provides a cloud platform for clinical research collaboration.

BiopharmaBiotechnologyClinical TrialsCloud ComputingMedicalPharmaceuticalSoftware
Series UnknownSep 28, 2020
Amount Raised: $176,162,304

China Diagnostic Medical Corporation is a diagnostic testing reagents maker.

BiopharmaPharmaceutical
Series BOct 20, 2008
Amount Raised: $16,500,000